News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

August 19, 2021

Huue and Ginkgo Bioworks Partner to Accelerate Production of Sustainable Dyes

Link

August 12, 2021

AngioDynamics Receives FDA Approval for PRESERVE Study

Link

Iaterion, Inc. Awarded NIH Grant for Nuclear Receptor Coligand Platform

Link

August 11, 2021

FDA-approved Trial Evaluates AngioDynamics’ NanoKnife for Prostate Tissue Ablation

Link

July 28, 2021

Study Reveals Gene Involved in Stem Rust Resistance in Wheat

https://www.isaaa.org/kc/cropbiotechupdate/article/default.asp?ID=18918

July 23, 2021

Caribou Raises $304M in One of Gene Editing's Most Lucrative IPOs

Link

July 21, 2021

Berkeley startup aims to be a game changer in autoimmune disease therapy

Link

July 19, 2021

With Focus on the 'Undruggable,' Biotech Raises $88.5M Series B from IPO-minded Investors

Link

July 14, 2021

Enable Biosciences Supports California Department of Public Health's CalScope Program to Survey COVID-19 Antibodies from Infection and Vaccination

Link

July 13, 2021

Tenaya Therapeutics Preclinical Research Supports Product Candidate for Heart Disease Indications

Link

July 12, 2021

Clinical Trial of CRISPR-Edited Cell Therapy Launched for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Link

July 3, 2021

Cannabinoids Are the Next Big Thing in the Pot Industry, But Who Can Mass-Produce It?

https://observer.com/2021/07/cannabinoids-are-the-next-big-thing-in-the-...

July 2, 2021

Caribou Biosciences Files for $100M IPO

Link

July 1, 2021

Amyris Completes First Major License For RNA COVID Vaccine Advancing Technology To Human Trials

Link

June 28, 2021

In Major CRISPR Milestone, Intellia Successfully Edits Genes Inside the Body

Link

June 10, 2021

A World First in Imaging Technology, Developed by Magnetic Insight

Link

May 20, 2021

Nanosys Acquires Leading MicroLED Company glō

Link

Tenaya Therapeutics Receives Orphan Drug Designation for Genetic Hypertrophic Cardiomyopathy Gene Therapy

Link

May 18, 2021

Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies

https://www.biospace.com/article/vedere-bio-is-bypassing-what-s-broken-t...

May 12, 2021

Berkeley Lights to Launch Subscription Option for Smaller Biotech Firms

https://www.genomeweb.com/business-news/berkeley-lights-launch-subscript...